Intro text to follow
Quote here from Ilise about dedication and vision.
|
Program
|
Indication
|
Phase I
Phase II
Phase III
Regulatory
|
Timeline
|
|
|---|---|---|---|---|
|
Cenobamate
|
Epilepsy
|
Focal-Onset Seizures |
Pre-filling
|
MAA filed |
Primary Generalized Tonic-Clonic Seizures |
Phase III
|
Expected to complete in 2022 |
||
Pediatric / Orphan |
Phase I / II
|
Expected to initiate in 2020 |
||
|
Non-Epilepsy
|
Bipolar Disorder |
Phase II
|
Under evaluation, programs could begin in late 2020 |
|
Neuropathic Pain |
Phase II
|
Under evaluation, programs could begin in late 2020 |
||
Anxiety Disorders |
Phase II
|
Under evaluation, programs could begin in late 2020 |
||